] Unquestionably, the solutions to many current problems,
] the treatments for many illnesses, and the pathways to
] new businesses have already been invented, but they are
] waiting on the sidelines.

...

] it's not only innovation that
] matters, it's the rate at which innovations are
] improved and brought to market. And this has declined
] precipitously since the bust. The result is a surplus of
] innovations, with vast numbers of potentially important
] advances being warehoused or shelved. This situation is
] alarming enough in itself, but even more worrisome is the
] fact that innovations don't have an unlimited shelf
] life: they are perishable and risk becoming unusable when
] the people associated with them move on to other
] endeavors. Another reason for concern is that warehoused
] innovations remain untested and deprived of the iterative
] improvements so critical to their journey from inception
] to implementation.

you have to register for this, but it's a great article on how innovation has accelerated but the conduit for commercializing it has essentially collapsed. This has validated my thinking on the subject, but changed my perceptions on it quite a bit. Upto now, I had considered it a purely supply-demand problem, but it is more complex than that as the system that transforms innovation into the mainstream has matured and atrophied to some degree. The system is irrevocably changing.

Our Innovation Backlog